Company news

HeartSciences Inc. news in 2024

HeartSciences Inc.'s news releases, calls and decks from 2024, newest first.

View company

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

December 15, 2024

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

November 12, 2024

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

September 11, 2024

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

September 11, 2024

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

July 28, 2024

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

July 24, 2024

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

July 10, 2024

HeartSciences Regains Compliance with Nasdaq Listing Requirements

June 3, 2024

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

May 19, 2024

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

April 23, 2024

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

March 25, 2024

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 13, 2024

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

March 11, 2024

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

March 5, 2024

HeartSciences Adds Key Advisor to its Scientific Advisory Board

February 25, 2024

HeartSciences Expands its Scientific Advisory Board

February 11, 2024

HeartSciences Appoints New Scientific Advisory Board Member

January 31, 2024

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

January 17, 2024